Committee Opinion No. 640: Cell-Free Dna Screening For Fetal Aneuploidy

@article{2015CommitteeON,
  title={Committee Opinion No. 640: Cell-Free Dna Screening For Fetal Aneuploidy},
  author={},
  journal={Obstetrics \& Gynecology},
  year={2015},
  volume={126},
  pages={e31–e37}
}
  • Published 1 September 2015
  • Medicine
  • Obstetrics & Gynecology
ABSTRACT Noninvasive prenatal screening that uses cell-free DNA from the plasma of pregnant women offers tremendous potential as a screening method for fetal aneuploidy. A number of laboratories have validated different techniques for the use of cell-free DNA as a screening test for fetal aneuploidy. All tests have a high sensitivity and specificity for trisomy 18 and trisomy 21, regardless of which molecular technique is used. Women whose results are not reported, indeterminate, or… Expand
Contingent prenatal screening for frequent aneuploidies with cell-free fetal DNA analysis.
TLDR
The results show that offering cf-DNA testing to women at high risk in traditional tests (including those with risks >1 in 50) significantly reduces false positives and, therefore, the number of invasive tests. Expand
Implications of fetoplacental mosaicism on cell‐free DNA testing: a review of a common biological phenomenon
  • F. Grati
  • Medicine
  • Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
  • 2016
TLDR
The established knowledge of placental genetics, derived from decades of prenatal diagnostic cytogenetics, is translated into the new cfDNA testing paradigm to assist in pretest prenatal counseling, when test limits and advantages are explained, and post-test counseling,When there is discordance between a screening result and the ‘truth’. Expand
Evaluation of a novel screening method for fetal aneuploidy using cell-free DNA in maternal plasma
TLDR
This new technology demonstrates equivalent test performance compared with alternative sequencing approaches, and demonstrates that each chromosome can be successfully interrogated using a single probe. Expand
Noninvasive Prenatal Testing by Cell-Free DNA: Technology, Biology, Clinical Utility, and Limitations
TLDR
Appropriate pre- and posttest counseling regarding the risks, benefits, limitations, and clinical utility of cell-free DNA testing is paramount. Expand
Cell‐free fetal DNA‐based noninvasive prenatal testing of aneuploidy
TLDR
NIPT is a screening test and needs confirmatory invasive testing in cases of a high‐risk (positive) result, but it is imperative that the implications of false positive and false negative results are investigated and considered in a clinical context. Expand
Noninvasive prenatal screening for fetal sex chromosome aneuploidies
TLDR
A vast array of published studies focusing on the clinical significance, detection methods, performance, and management of positive SCA results following screening are evaluated with the aim of facilitating a comprehensive and systematic understanding of NIPS for SCAs. Expand
Low Fetal Fraction of Cell-free DNA Identified by Non-invasive Prenatal DNA Testing: Possible Causes, Clinical Significance, and Tactics
TLDR
The study showed that in women carrying fetuses with trisomy 18 or 13 or monosomy X, mean fetal fraction in the first trimester was significantly lower than normal, and other methods of prenatal diagnosis should be recommended for overweight and obese women. Expand
Performance of cell-free DNA sequencing-based non-invasive prenatal testing: experience on 36,456 singleton and multiple pregnancies
TLDR
A retrospective analysis of a large cohort of consecutive patients who had whole-genome sequencing-based NIPT for classic trisomies and SCA shows excellent detection rates and low false positive rates. Expand
Chorionic villus sampling fails to confirm mosaic trisomy 21 fetus after positive cell‐free DNA
TLDR
A case of a low-risk multigravida woman who underwent elective first trimester cfDNA testing to determine fetal gender and results, presented, show no evidence of numerical abnormality for chromosomes 13, 18, 21, X, and Y. Expand
Ethical and practical challenges in providing noninvasive prenatal testing for chromosome abnormalities: an update
TLDR
It is believed that the same ethical and legal principles that were considered in the justification of conventional prenatal screening can be used to assess the appropriateness of additional NIPT applications. Expand
...
1
2
3
4
5
...